series-b
Stage
2020
Founded
3
Investors
About
Imagene provides a disruptive, AI-based genomic testing solution to leverage the patient's historical data for personalized therapy, focusing on cancer diagnostic through pathological and molecular testing.
Explore Imagene's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.